Provenance du réseau au premier degré de Chad Brines
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Chad Brines via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Augmenix, Inc.
 Augmenix, Inc. Medical SpecialtiesHealth Technology Augmenix, Inc. develops hydrogel technology to improve outcomes in radiation oncology and surgery. Its products include TraceIT Tissue Marker and SpaceOAR System, which is an absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy. The company was founded by Amarpreet S. Sawhney in 2008 and is headquartered in Bedford, MA. | Medical Specialties | Chief Executive Officer Chairman | |
Axtria, Inc.
 Axtria, Inc. Packaged SoftwareTechnology Services Axtria, Inc. provides customized analytics software and client consulting services. The firm?s solutions include decision science, commercial operations cloud and cloud information management. The company was founded by Jaswinder S. Chadha and Navdeep Chadha in 2010 and is headquartered in Berkeley Heights, NJ. | Packaged Software | Director/Board Member Founder Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
A.T. Kearney, Inc.
 A.T. Kearney, Inc. Miscellaneous Commercial ServicesCommercial Services A.T. Kearney, Inc. engages in the provision of management consulting services. Its services include strategic, operational and technology consulting executive search services. The company was founded by Andrew Thomas Kearney in 1926 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bryan Cave Leighton Paisner LLP
 Bryan Cave Leighton Paisner LLP Miscellaneous Commercial ServicesCommercial Services Bryan Cave Leighton Paisner LLP provides legal services. It is a business and litigation firm with a diverse client base, includes business, financial institutions and not-for-profit organizations, government entities and individual clients. The firm represents business, financial, institutional and individual clients, including publicly held multinational corporations, large and mid-sized privately held companies, partnerships and emerging companies. The company was founded by Robert D. Klingler in 1873 and is headquartered in St. Louis, MO. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Arizona State University | College/University | Undergraduate Degree | |
| University of London | College/University | Graduate Degree | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Rensselaer Polytechnic Institute | College/University | Masters Business Admin | |
| University of Kansas | College/University | Doctorate Degree | |
| Youngstown State University | College/University | Undergraduate Degree | |
| Indian Institute of Technology New Delhi | College/University | Undergraduate Degree Undergraduate Degree | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
marketRx LLC
 marketRx LLC Miscellaneous Commercial ServicesCommercial Services marketRx LLC offers analytics, market research and software services to life sciences companies. It delivers sales management and operations, brand marketing and product management, and market research services. The company was founded in 2000 and is headquartered in Bridgewater, NJ. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| New York Medical College | College/University | Corporate Officer/Principal | |
| Seoul National University | College/University | Doctorate Degree | |
| CELLTRION HEALTHCARE CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
The Indus Entrepreneurs
 The Indus Entrepreneurs Miscellaneous Commercial ServicesCommercial Services The Indus Entrepreneurs is a non-profit organization. It provides mentoring, networking, education and funding to entrepreneurs. The company was founded in 1992 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Director/Board Member | |
New Jersey Technology Council
 New Jersey Technology Council Miscellaneous Commercial ServicesCommercial Services New Jersey Technology Council provides business development, education and advocacy services. It serves communications, e-business, multimedia, consumer technologies, manufacturing, engineering and energy sectors. The company was founded in 1996 and is headquartered in New Brunswick, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University Of The West Indies | College/University | Undergraduate Degree | |
TiE Boston
 TiE Boston Investment ManagersFinance TiE Boston is a private equity firm founded by by Desh Deshpande in 1997. The firm is headquartered in Boston, MA. | Investment Managers | Corporate Officer/Principal | |
Ostial Corp.
 Ostial Corp. Medical/Nursing ServicesHealth Services Ostial Corp. develops catheter-based delivery system combined with a bare metal stent. The firm allows physicians to perform aorto-ostial interventions with precision and predictability. The company was founded by Fred Khosravi in 2008 and is headquartered in Campbell, CA. | Medical/Nursing Services | Director/Board Member | |
Silver Creek Pharmaceuticals, Inc.
 Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
| University of Texas at El Paso | College/University | Graduate Degree | |
Worley Field Services Ltd.
 Worley Field Services Ltd. Engineering & ConstructionIndustrial Services Part of Jacobs Solutions, Inc., Worley Field Services Ltd. is a British company that provides construction services. The company is based in Brentford, UK. Founded in 1948. | Engineering & Construction | Corporate Officer/Principal | |
| Connecticut School of Law University Of | College/University | Graduate Degree | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
| South Asian Pharmaceutical Council | Director/Board Member | ||
| Panjab Digital Library | Director/Board Member | ||
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sofregen Medical, Inc.
 Sofregen Medical, Inc. BiotechnologyHealth Technology Sofregen Medical, Inc. develops innovative silk-based solutions for soft tissue defects. Its products: SERI silk derived surgical scaffold is knitted scaffold made from ultra-pure, sterile, silk-derived bioprotein that facilitates neovascularization and native tissue regeneration over time and Sofregen technology a silk derived material for medical application. The company was founded by Anh Hoang and Howard J. Weisman on May 19, 2014 and is headquartered in Cambridge, MA. | Biotechnology | President | |
Instylla, Inc.
 Instylla, Inc. Miscellaneous Commercial ServicesCommercial Services Instylla, Inc. operates as a biotechnology company. Its focus is to leverage hydrogel technology to create differentiated liquid embolics for interventional radiology with a specific initial focus on interventional oncology and peripheral hemostasis. The company was founded by Amarpreet Sawhney and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Tulavi Therapeutics, Inc.
 Tulavi Therapeutics, Inc. BiotechnologyHealth Technology Tulavi Therapeutics, Inc. develops therapeutics to treat neurally mediated diseases. It helps to treat aberrant neural reflex arcs in peripheral and visceral diseases. The company was founded was founded by Corinne Bright, Fred Khosravi and Henry Chen and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member | |
HiFiBiO Inc.
 HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology HiFiBiO Inc. develops and manufactures pharmaceutical products. It specializes in antibodies, that mobilize the human immune system to combat cancer, autoimmune disorders, and other unmet medical needs. The company was founded by Liang Schweizer, Fred Dom, Andrew Griffiths, David Weitz, Bradley Bernstein, J?r?me Bibette, and Robert Nicol and is headquartered in Paris, France. | Pharmaceuticals: Major | Human Resources Officer | |
| Celltrion Healthcare Japan KK | President | ||
Rejoni, Inc.
 Rejoni, Inc. BiotechnologyHealth Technology Rejoni, Inc. engages in the provision of biotechnology services. It focuses on developing products that improve the outcomes of minimally invasive and other gynecological surgical procedures. The company was founded in June 2020 and is headquartered in Bedford, MA. | Biotechnology | President Chief Executive Officer | |
Novalgen Ltd.
 Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Cellemedy Co., Ltd.
 Cellemedy Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Cellemedy Co., Ltd. develops next-generation cancer treatments to improve the health of people suffering from cancer. The company is based in Seongnam-si, South Korea. The South Korean company was founded in 2016. The CEO is Ha-Chul Kim. | Miscellaneous Commercial Services | President | |
Cybernetix Ventures Managemnet Co LLC
 Cybernetix Ventures Managemnet Co LLC Investment ManagersFinance Cybernetix Ventures Management Co.LLC (Cybernetix Ventures ) is a venture capital firm founded in 2018 by Mark Martin and Fady Saad. The firm headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
| Novelgen Co. Ltd(South Korea) | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 36 |
| Royaume-Uni | 7 |
| Corée du Sud | 5 |
| Inde | 3 |
| Bermudes | 2 |
Sectorielle
| Health Technology | 20 |
| Consumer Services | 15 |
| Commercial Services | 9 |
| Finance | 3 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 52 |
| Corporate Officer/Principal | 26 |
| President | 14 |
| Undergraduate Degree | 14 |
| Independent Dir/Board Member | 14 |
Relations les plus connectées
| Insiders | |
|---|---|
| Leslie Williams | 19 |
| Jim O'Shea | 16 |
| Amarpreet S. Sawhney | 15 |
| Merilee Raines | 13 |
| Jaswinder S. Chadha | 9 |
| Christopher White | 9 |
| Rabia Ozden | 9 |
| Daniel M. Bollag | 8 |
| Philip Strassburger | 7 |
| Seung Suh Hong | 7 |
| Amar Sawhney | 7 |
| Tracy Smith | 6 |
| Karen-Leigh Edwards | 6 |
| Nicole Carta | 4 |
| Patricia Kitchen | 4 |
- Bourse
- Insiders
- Chad Brines
- Connexions Sociétés
